HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity

Journal of Cellular Physiology

Volumn 203, Issue 3, 2005, Pages 547-556

  Gibellini, Davide ^a   Re, Maria Carla ^a   Ponti, Cristina ^b   Vitone, Francesca ^a   Bon, Isabella ^a   Fabbri, Greta ^a   Di Iasio, Maria Grazia ^b   Zauli, Giorgio ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 8; COMPLEMENTARY DNA; FLICE INHIBITORY PROTEIN; ISOPROTEIN; MESSENGER RNA; RNA; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 10; CASPASE 8; CASPASES; CD4-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; DNA, COMPLEMENTARY; DOWN-REGULATION; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV-1; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MUTATION; RNA, MESSENGER; RNA, VIRAL; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 18244394529     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20252     Document Type: Article

References (64)

1. Agwale SM, Shata MT, Reitz MS, Jr., Kalyanaraman VS, Gallo RC, Popovic M, Hone DM. 2002. A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice. Proc Natl Acad Sci USA 99:10037-10041.
2. Askenazi A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Cancer Rev 2:420-430.
3. Badley AD, Parato K, Cameron DW, Kravcik S, Phenix BN, Ashby D, Kumar A, Linch DH, Tschopp J, Angel JB. 1999. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ 6:420-432.
4. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ. 1992. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med 326:1385-1391.
5. Borgatti P, Zauli G, Colamussi ML, Gibellini D, Previati M, Cantley LL, Capitani S. 1997. Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and AKT/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur J Immunol 27:2805-2811.
6. Brigati C, Giacca M, Noonan DM, Albini A. 2003. HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol Lett 220:57-65.
7. Burns TF, El-Deiry WS. 2001. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J Biol Chem 276:37879-37886.
8. Caputo A, Sodroski JG, Haseltine WA. 1990. Constitutive expression of HIV-I Tat protein in human Jurkat T cells using a BK virus vector. J Acquir Immune Defic Syndr 3:372-379.
9. Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Straus SE, Lenardo MJ. 2002. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395-399.
10. De la Fuente C, Santiago F, Deng L, Eadie C, Zilberman I, Kehn K, Maddukuri A, Baylor S, Wu K, Lee CG, Pumfery A, Kashanchi F. 2002. Gene expression profile of HIV-1 Tat expressing cells: A close interplay between proliferative and differentiation signals. BMC Biochem 3:14-24.
11. De Marchi F, d'Adda di Fagagna F, Falaschi A, Giacca M. 1996. Activation of transcription factor NF-kB by the Tat protein of human immunodeficiency virus type 1. J Virol 70:4427-4437.
12. Ensoli B, Cafaro A. 2002. HIV-1 Tat vaccines. Virus Res 82:91-101.
13. Ensoli B, Barillari G, Zaki Salahuddin S, Gallo RC, Wong-Stall F. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84-86.
14. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 93:7464-7469.
15. Flores SC, Marecki JC, Harper KP, Bose SK, Nelson SK, McCord JM. 1993. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells. Proc Natl Acad Sci USA 90:7632-7636.
16. Gallo RC. 1999. Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine. Proc Natl Acad Sci USA 96:8324-8326.
17. Gibellini D, Re MC, Ponti C, Maldini C, Celeghini C, Cappellini A, La Placa M, Zauli G. 2001. HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. Cell Immunol 207:89-99.
18. Gibellini D, Re MC, La Placa M, Zauli G. 2002. Differential gene expression in HIV-1 tat-expressing lymphoblastoid Jurkat T CD4+ cells. Virus Res 90:337-345.
19. Gronbaek K, Dalby T, Zeuthen J, Ralfkiaer E, Guidberg P. 2000. The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood 95:2184-2185.
20. Harada K, Toyoka S, Shivapurkar N, Maitra A, Reddy JL, Matta H, Miyajima K, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Chaudhary P, Gazdar PM. 2002. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 62:5897-5901.
21. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. 1997. Inhibition of death receptors signals by cellular FLIP. Nature 388:190-195.
22. Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, Young RA, Aldovini A. 2003. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat Med 9:191-197.
23. Jeremias I, Herr I, Boehler T, Debatin KM. 1998. TRAIL/Apo-2-ligand- induced apoptosis in human T cells. Eur J Immunol 28:143-152.
24. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J. 2000. The caspase-8 inhibitor c-FLIP promotes activation of NF-kB and Erk signaling pathways. Curr Biol 10:640-648.
25. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, Tijoe IM, Smith CA, Herzenberg LA. 1997. Interleukin-1β converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV Infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J Exp Med 186:1365-1372.
26. Kim DW. 2001. Real time quantitative PCR. Exp Mol Med 33:101-109.
27. Kim H, Warthenby KA, Georgantas R III, Wingard J, Civin C. 2002. Human CD34+ hematopoietic stem/progenitor cells express high levels of Flip and are resistant to fas-mediated apoptosis. Stem Cells 20:174-182.
28. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D, Ashkenazi A. 2001. Death Receptor Recruitment of endogenous Caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276:46639-46646.
29. Krammer PH. 2000. CD95's deadly mission in the immune system. Nature 407:789-795.
30. Krueger A, Baumann S, Krammer PH, Kirchhoff S. 2001. FLICE-inhibitory proteins: Regulators of death receptors-mediated apoptosis. Mol Cell Biol 21:8247-8254.
31. Leblanc HN, Ashkenazi A. 2003. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10:66-75.
32. Liabakk NB, Sundan A, Torp S, Aukrust P, Froland SS, Espevik T. 2002. Development, characterization and use of monoclonal antibodies against sTRAIL: Measurement of sTRAIL by ELISA. J Immunol Meth 259:119-128.
33. Lum J, Pilon AA, Sanchez-Dardon J, Phenix BN, Kim JE, Mihowich J, Jamison K, Hawley-Foss N, Lynch DH, Badley AD. 2001. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2L. J Virol 75:11128-11136.
34. McCloskey TW, Ott M, Tribble E, Khan SA, Teichberg S, Paul MO, Pahwa S, Verdin E, Chirmule N. 1997. Dual role of HIV Tat in regulation of apoptosis in T cells. J Immunol 158:1014-1019.
35. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. 2001. NF-kB signals induce the expression of C-FLIP. Mol Cell Biol 21:5299-5305.
36. Mischiati C, Pironi F, Milani D, Giacca M, Mirandola P, Capitani S, Zauli G. 1999. Extracellular. HIV-1 Tat protein differentially activates the JNK and ERK/Mapk pathways in CD4 T cells. AIDS 10:1637-1645.
37. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. 2000. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 60:4122-4129.
38. Miura Y, Misawa N, Maeda N, Inagaki Y, Tanaka Y, Ito M, Kayagaki N, Yamamoto N, Yagita H, Mizusawa H, Koyanagi Y. 2001. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4 T Cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med 193:651-660.
39. Ng PW, Porter AG, Janicke RU. 1999. Molecular cloning and characterization of two novel pro-apoptotic isoforms of Caspase-10. J Biol Chem 274:10301-10308.
40. Panka DJ, Mano T, Suhara T, Walsh K, Mier JW. 2001. Phosphatidylinositol 3-kinase/AKT activity regulates c-FLIP expression in tumor cells. J Biol Chem 276:6893-6896.
41. Park WS, Lee JH, Shin MS, Park JY, Kim HS, Lee JH, Kim YS, Lee SN, Xiao W, Park CH, Lee SH, Yoo NJ, Lee JY. 2002. Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 21:2919-2925.
42. Pauza CD, Trivedi P, Wallace M, Ruckwardt TJ, Le Buanec H, Lu W, Bizzini B, Burny A, Zagury D, Gallo RC. 2000. Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci USA 97:3515-3519.
43. Perez D, White E. 2003. E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S. J Virol 77:2651-2662.
44. Richardson MW, Mirchandani J, Silvera P, Regulier EG, Capini C, Bojczuk PM, Hu J, Gracely EJ. 2002. Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: Induction of humoral and cellular immune responses. DNA Cell Biol 21:637-651.
45. Scaffidi C, Schmitz I, Krammer PH, Peter ME. 1999. The role c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274:1541-1548.
46. Sharma V. 2003. Current perspectives on cytokines for anti-retroviral therapy in AIDS related B-cell lymphomas. Curr Drug Targets Infect Disord 3:137-149.
47. Shin MS, Kim HS, Kang CS, Park WS, Kim SY, Lee SN, Lee JH, Park JY, Jang JJ, Kim CW, Kim SH, Lee JY, Yoo NJ, Lee SH. 2002. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99:4094-4099.
48. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H. 2002. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J 21:4520-4530.
49. Stylianou E, Yndestad A, Sikkeland LI, Bjerkeli V, Damas JK, Haug T, Eiken HG. 2002. Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients. Clin Exp Immunol 130:279-285.
50. Tepper CG, Seldin MF. 1999. Modulation of caspase-8 and FLICE inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma. Blood 94:1727-1737.
51. Tibbetts MD, Zheng L, Lenardo MJ. 2003. The death effector domain protein family: Regulators of cellular homeostasis. Nat Immunol 4:404-409.
52. Velthuis JHL, Rouschop KM, de Bont HJ, Mulder GJ, Nagelkerke JF. 2002. Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis. J Biol Chem 277:24631-24637.
53. Walczak H, Bouchon A, Stahl H, Krammer PH. 2000. Tumor necrosis factor-related apoptosis inducing capacity on bcl-2 or bcl-XL-overexpressing chemotherapy-resistant tumor cells. Cancer Res 60:3051-3057.
54. Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM, Strauss SE, Lenardo MJ. 1999a. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98:47-58.
55. Wang Z, Morris GF, Reed JC, Kelly GD, Morris CB, 1999b. Activation of Bcl-2 promoter directed gene expression by the human immunodeficiency virus type 1 Tat protein. Virology 257:502-510.
56. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. 2001. Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 98:13884-13888.
57. Wendling U, Walczak H, Dorr J, Jaboci C, Weller M, Krammer PH, Zipp F. 2000. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells. Cell Death Differ 7:637-644.
58. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500.
59. Yamada H, Tada-Oikawa S, Uchida A, Kawanishi S. 1999. TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells. Biochem Biophys Res Commun 265:130-133.
60. Yang Y, Tikhonov I, Ruckwardt TJ, Djavani M, Zapata JC, Pauza D, Salvato MS. 2003. Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4+ cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J Virol 77:6700-6708.
61. Zauli G, La Placa M, Vignoli M, Re MC, Gibellini D, Furlini G, Milani D, Marchisio M, Mazzoni M, Capitani S. 1995a. An autocrine loop of HIV type 1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal human immunodeficiency virus type 1 long terminal repeat transactivating activity. J AIDS 10:306-316.
62. Zauli G, Gibellini D, Caputo A, Bassini A, Negrini M, Monne M, Mazzoni M, Capitani S. 1995b. The human immunodeficiency virus type-1 (HIV-1) Tat protein upregulates Bcl-2 gene expression in Jurkat T cell lines and primary peripheral blood mononuclear cells. Blood 86:3823-3834.
63. Zauli G, Gibellini D, Celeghini C, Mischiati C, Bassini A, La Placa M, Capitani S. 1996. Pleiotropic effects of immobilized vs soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis and HIV-1 LTR transactivation in purified CD4+ T lymphocytes. J Immunol 157:2216-2224.
64. Zhang M, Li X, Pang X, Ding L, Wood O, Clouse K, Hewlett I, Dayton AI. 2001. Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: Upregulation of trail in primary human macrophages by HIV-1 tat. J Biomed Sci 8:290-296.